Orlando, FL -- (SBWIRE) -- 10/14/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Wells Fargo & Co(NYSE:WFC), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA).
Wells Fargo & Co(NYSE:WFC) shares decreased 0.02% to $41.44. Profit at Wells Fargo & Co (WFC.N) rose by a better-than-expected 13% in the third quarter, as the largest U.S. mortgage lender made up for a decline in that business by releasing a large chunk of money set aside for bad loans. The company’s net income applicable to common shareholders rose to $5.32 billion, or 99 cents per share, from $4.72 billion, or 88 cents per share, a year earlier. Analysts, on average, estimated Wells Fargo would earn 97 cents per share. Total revenue dipped to $20.5 billion from $21.2 billion a year earlier.
Additionally, the company on Oct. 8 said it is presenting $1,000 checks to 520 high school student winners in communities across the country from the company's "CollegeSTEPS® expanded sweepstakes."
Are investors worried about the recent updates with WFC? Find out with a free trend analysis HERE
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares dropped 21.26% to $4.26. The company on Oct. 9 announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA). With a median follow up of 24 months, serious arterial thrombosis occurred in 11.8% of Iclusig-treated patients: cardiovascular events 6.2%, cerebrovascular events 4.0% and peripheral vascular events 3.6% (some patients had more than one type of event). This compares to 8.0% after 11 months of follow up reflected in the current U.S. prescribing information. At 24 months, serious venous occlusion occurred in 2.9% of Iclusig-treated patients, compared to 2.2% in the current U.S. prescribing information.
Is ARIA going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)